Cyanoalkylamino derivatives as protease inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7371747
APP PUB NO 20050014941A1
SERIAL NO

10495387

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel cyanoalkylamino derivatives that are inhibitors of cysteine protease such as cathepsins K, S, B and L, in particular cathepsin K Pharmaceutical composition comprising these compounds, method of treating diseases mediated by unregulated cysteine protease activity, in particular cathepsin K utilizing these compounds and methods of preparing these compounds are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK FROSST CANADA LTD16711 TRANS-CANADA HIGHWAY KIRKLAND QUEBEC H9H 3L1

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Black, Cameron Baie d'Urfe, CA 51 1453
Crane, Sheldon N Rue D'Amalfi, CA 9 8
Davis, Dana Santa Clara, CA 12 155
Setti, Eduardo L San Mateo, CA 10 108

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation